AMUNDI ASSET MANAGEMENT US, INC. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2021$405,000
-5.6%
400,0000.0%0.00%
Q4 2020$429,000
+2.1%
400,0000.0%0.00%
Q3 2020$420,000
-14.1%
400,0000.0%0.00%
-100.0%
Q2 2020$489,000
+16.7%
400,0000.0%0.00%0.0%
Q1 2020$419,000
-0.9%
400,0000.0%0.00%
Q4 2019$423,000
+7.6%
400,0000.0%0.00%
-100.0%
Q3 2019$393,000
-5.3%
400,0000.0%0.00%
Q2 2019$415,000
-88.4%
400,000
-88.5%
0.00%
-100.0%
Q1 2019$3,567,000
+6.4%
3,487,000
+3.5%
0.01%
+66.7%
Q4 2018$3,351,000
-15.1%
3,370,000
-9.1%
0.00%
-40.0%
Q3 2018$3,949,000
-2.6%
3,706,000
-7.7%
0.01%
-16.7%
Q2 2018$4,056,000
-65.4%
4,015,000
-67.9%
0.01%
-68.4%
Q1 2018$11,736,000
-2.0%
12,501,000
+4.0%
0.02%
+5.6%
Q4 2017$11,975,000
+47.7%
12,020,000
+50.2%
0.02%
-30.8%
Q3 2017$8,105,0008,000,0000.03%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2021
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 19,413,000$19,245,6111.50%
SSI INVESTMENT MANAGEMENT LLC 9,386,000$9,219,5660.65%
PFM Health Sciences, LP 15,000,000$14,771,5200.57%
RWC Asset Management LLP 11,000,000$10,848,4750.52%
Sonora Investment Management Group, LLC 6,280,000$6,184,8580.52%
ADVENT CAPITAL MANAGEMENT /DE/ 24,020,000$23,654,1280.46%
Lombard Odier Asset Management (Europe) Ltd 7,224,000$7,124,4890.34%
MACKAY SHIELDS LLC 10,123,000$9,943,5200.28%
PALISADE CAPITAL MANAGEMENT, LP 9,478,000$9,323,9830.25%
Nicholas Investment Partners, LP 2,940,000$2,887,8680.20%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders